Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CPIX
DateTimeSourceHeadlineSymbolCompany
10/05/202421:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
10/05/202421:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202422:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202421:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202421:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202421:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLORĀ® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202421:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202421:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202422:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202322:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202321:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202322:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202322:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
17/11/202322:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202322:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202321:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
03/11/202321:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202320:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
17/10/202322:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
13/10/202314:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202321:05PR Newswire (US)NEW VIBATVĀ® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:CPIX

Your Recent History

Delayed Upgrade Clock